SINGAPORE, Nov 11 (Reuters) - Shire, a specialist in
rare diseases, aims to double Asian sales by 2020, as it targets
markets including China, where it hopes to put its haemophilia
drugs on a reimbursement list being updated this year for the
first time since 2009.
Read more
No comments:
Post a Comment